Interdepartmental Division of Critical Care Medicine, Toronto General Hospital, University of Toronto, Toronto, Canada.
Department of Thoracic Surgery, Toronto General Hospital, University of Toronto, Toronto, Canada.
J Cardiothorac Vasc Anesth. 2022 Dec;36(12):4296-4304. doi: 10.1053/j.jvca.2022.07.020. Epub 2022 Jul 30.
A paucity of data supports the use of transesophageal echocardiography (TEE) for bedside extracorporeal membrane oxygenation (ECMO) cannulation. Concerns have been raised about performing TEEs in patients with COVID-19. The authors describe the use and safety of TEE guidance for ECMO cannulation for COVID-19.
Single-center retrospective cohort study.
The study took place in the intensive care unit of an academic tertiary center.
The authors included 107 patients with confirmed SARS-CoV-2 infection who underwent bedside venovenous ECMO (VV ECMO) cannulation under TEE guidance between May 2020 and June 2021.
TEE-guided bedside VV ECMO cannulation.
Patient characteristics, physiologic and ventilatory parameters, and echocardiographic findings were analyzed. The primary outcome was the number of successful TEE-guided bedside cannulations without complications. The secondary outcomes were cannulation complications, frequency of cannula repositioning, and TEE-related complications.
TEE-guided cannulation was successful in 99% of the patients. Initial cannula position was adequate in all but 1 patient. Fourteen patients (13%) required cannula repositioning during ECMO support. Forty-five patients (42%) had right ventricular systolic dysfunction, and 9 (8%) had left ventricular systolic dysfunction. Twelve patients (11%) had intracardiac thrombi. One superficial arterial injury and 1 pneumothorax occurred. No pericardial tamponade, hemothorax or intraabdominal bleeding occurred in the authors' cohort. No TEE-related complications or COVID-19 infection of healthcare providers were reported during this study.
Bedside TEE guidance for VV ECMO cannulation is safe in patients with severe respiratory failure due to COVID-19. No tamponade or hemothorax, nor TEE-related complications were observed in the authors' cohort.
关于经食管超声心动图(TEE)在床边体外膜肺氧合(ECMO)置管中的应用,数据资料有限。人们对在 COVID-19 患者中进行 TEE 检查表示担忧。作者描述了 TEE 指导 COVID-19 患者 ECMO 置管的使用情况和安全性。
单中心回顾性队列研究。
研究在学术性三级中心的重症监护病房进行。
作者纳入了 2020 年 5 月至 2021 年 6 月期间在 TEE 指导下行床边静脉-静脉 ECMO(VV ECMO)置管的 107 例确诊 SARS-CoV-2 感染患者。
TEE 指导下床边 VV ECMO 置管。
分析患者特征、生理和通气参数以及超声心动图结果。主要结局是无并发症的 TEE 指导下床边置管的成功次数。次要结局是置管并发症、置管重新定位的频率和 TEE 相关并发症。
99%的患者 TEE 引导置管成功。除 1 例患者外,初始导管位置均合适。在 ECMO 支持期间,有 14 例患者(13%)需要重新定位导管。45 例患者(42%)存在右心室收缩功能障碍,9 例患者(8%)存在左心室收缩功能障碍。12 例患者(11%)存在心内血栓。1 例发生浅表性动脉损伤,1 例发生气胸。在作者的研究队列中,未发生心包填塞、血胸或腹腔内出血。在研究期间,未报告与 TEE 相关的并发症或医护人员 COVID-19 感染。
在因 COVID-19 导致严重呼吸衰竭的患者中,床边 TEE 指导 VV ECMO 置管是安全的。在作者的研究队列中,未观察到填塞或血胸,也未观察到与 TEE 相关的并发症。